Artemisia Arborescens Essential Oil Composition, Enantiomeric
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Retention Indices for Frequently Reported Compounds of Plant Essential Oils
Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5. -
Picrotoxin-Like Channel Blockers of GABAA Receptors
COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1). -
NTP Annual Report 2012
National Toxicology Program U.S. Department of Health and Human Services Annual Report 2012 National Toxicology Program ANNUAL REPORT for Fiscal Year 2012 National Institute of Environmental Health Sciences National Institutes of Health National Center for Toxicological Research Food and Drug Administration National Institute for Occupational Safety and Health Centers for Disease Control and Prevention September 2013 Department of Health and Human Services National Toxicology Program NIH Publication No. 13-5970 Table of Contents Letter from the NIEHS/NTP Director ...................................................................................................... 1 1. National Toxicology Program: Mission And Goals ....................................................................... 3 A. Organizational Structure and Oversight ...................................................................................... 4 B. Training Programs ....................................................................................................................... 6 C. Advisory Boards and Committees ............................................................................................... 6 i. NTP Executive Committee .................................................................................................6 ii. NTP Board of Scientific Counselors ...................................................................................7 iii. Scientific Advisory Committee on Alternative Toxicological Methods .................................9 -
Erowid Extracts — Number 13 / November 2007 Erowid Extracts Table of Contents Number 13, November 2007
Erowid® Extracts D OCUMENTING THE C OMPLEX R ELATIONSHIP B ETWEEN H UMANS AN D P SYCHOACTIVES November 2007 Number 13 “The problem to be faced is: how to combine loyalty to one’s own tradition with reverence for different traditions.” — Abraham J. Heschel The Absinthe Enigma • Wormwood and Thujone • P. viridis vs. M. tenuiflora Varieties of Nicotine Experience • Khat Legal Challenges LETTERS & FEEDBACK Hi there Erowid staff, First of all, thank you for such Awesome website! A more thoughtfully a wonderful site. I’m not a serious compiled compendium of information I’m just writing to say how much I recreational user, but having some on the topic of psychoactives does appreciate your website. My father chronic pain issues, I tend to experiment not exist—at least not for the public showed it to me several years ago a little to find ways to alleviate the at large. Bravo. and it’s been fun to watch it grow pain (aside from standard Rx’s from in quality and content over the — ANOnymOus doctors). […] years. My dad adjunctly teaches a Letter to Erowid psychopharmacology class in town and Keep up the good work. Although always lists Erowid on his syllabus of some might look at Erowid negatively, recommended readings. I’m a college I look at it positively, in the sense that After looking up information on the student and am surprised, once I I’m smart enough to research things antitussive properties of DXM, how start talking to other kids, how many before I try them, and hopefully keep shocked I was to find your website, of them know about the information myself from an early demise. -
Assessment Report on Salvia Officinalis L., Folium and Salvia Officinalis L., Aetheroleum Final
20 September 2016 EMA/HMPC/150801/2015 Committee on Herbal Medicinal Products (HMPC) Assessment report on Salvia officinalis L., folium and Salvia officinalis L., aetheroleum Final Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Herbal substance(s) (binomial scientific name of Salvia officinalis L., folium and the plant, including plant part) Salvia officinalis L., aetheroleum Herbal preparation(s) a) Comminuted herbal substance b) Liquid extract (DER 1:1), extraction solvent ethanol 70% V/V c) Dry extract (DER 4-7:1), extraction solvent water d) Liquid extract (DER 1:3.5-5), extraction solvent ethanol 31.5% V/V e) Liquid extract (DER 1:4-5) extraction solvent ethanol 50% V/V f) Liquid extract (DER 1:4-6), extraction solvent liquor wine:ethanol 96% V/V (38.25:61.75 m/m) g) Tincture (ratio of herbal substance to extraction solvent 1:10) extraction solvent ethanol 70% V/V Pharmaceutical form(s) Comminuted herbal substance as herbal tea for oral use. Comminuted herbal substance for infusion preparation for oromucosal or cutaneous use. Herbal preparations in solid or liquid dosage forms for oral use. Herbal preparations in liquid or semi-solid dosage forms for cutaneous use or for oromucosal use. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. -
Plant-Based Medicines for Anxiety Disorders, Part 2: a Review of Clinical Studies with Supporting Preclinical Evidence
CNS Drugs 2013; 24 (5) Review Article Running Header: Plant-Based Anxiolytic Psychopharmacology Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence Jerome Sarris,1,2 Erica McIntyre3 and David A. Camfield2 1 Department of Psychiatry, Faculty of Medicine, University of Melbourne, Richmond, VIC, Australia 2 The Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, VIC, Australia 3 School of Psychology, Charles Sturt University, Wagga Wagga, NSW, Australia Correspondence: Jerome Sarris, Department of Psychiatry and The Melbourne Clinic, University of Melbourne, 2 Salisbury Street, Richmond, VIC 3121, Australia. Email: [email protected], Acknowledgements Dr Jerome Sarris is funded by an Australian National Health & Medical Research Council fellowship (NHMRC funding ID 628875), in a strategic partnership with The University of Melbourne, The Centre for Human Psychopharmacology at the Swinburne University of Technology. Jerome Sarris, Erica McIntyre and David A. Camfield have no conflicts of interest that are directly relevant to the content of this article. 1 Abstract Research in the area of herbal psychopharmacology has revealed a variety of promising medicines that may provide benefit in the treatment of general anxiety and specific anxiety disorders. However, a comprehensive review of plant-based anxiolytics has been absent to date. Thus, our aim was to provide a comprehensive narrative review of plant-based medicines that have clinical and/or preclinical evidence of anxiolytic activity. We present the article in two parts. In part one, we reviewed herbal medicines for which only preclinical investigations for anxiolytic activity have been performed. In this current article (part two), we review herbal medicines for which there have been both preclinical and clinical investigations for anxiolytic activity. -
Variability of Thujone Content in Essential Oil Due to Plant Development and Organs from Artemisia Absinthium L
Journal of Applied Botany and Food Quality 92, 100 - 105 (2019), DOI:10.5073/JABFQ.2019.092.014 Department of Medicinal and Aromatic Plants, Szent István University, Budapest, Hungary Variability of thujone content in essential oil due to plant development and organs from Artemisia absinthium L. and Salvia officinalis L. Huong Thi Nguyen*, Péter Radácsi, Péter Rajhárt, Éva Zámboriné Németh (Submitted: March 4, 2019; Accepted: March 22, 2019) Summary 5.0 mg thujone/day/person for a maximum duration of use of 2 weeks (EMA/HMPC, 2008b). The study compared changes in essential oil content and its thujone Although both α- and β-thujones are also found naturally in con- ratio in two popular herbs (Artemisia absinthium L. and Salvia offi- siderable concentrations in other essential oils (EO) such as tansy cinalis L.), pertaining to plant development and plant organs. Both (Tanacetum vulgare), white-cedar (Thuja occidentalis), and other species were harvested in 2018 at the vegetative, floral budding, Artemisia and Achillea species (PELKONEN et al., 2013), the above flowering and after flowering phases; flowers and leaves were sam- mentioned A. absinthium and S. officinalis species are the most cha- pled separately. The essential content is always higher in the flowers racteristic ones as well as being found in numerous preparations fre- than in the leaves at the same phenophase in both species we exa- quently used by consumers. mined. Decreased essential oil content in both organs during the The mean concentration of α- and β-thujones in A. absinthium oils developmental phases was also common to both species. In S. -
Sage, Skullcap, and Castor Oil
Sage, Skullcap, and Castor Oil “In this conversation on herbal medicine I want to briefly cover my use of three herbs, Sage, Skullcap, and Castor Oil. I have used these herbs in combination in the treatment of diabetic neuropathy, and in the example of the case history to follow, to save a patient’s leg scheduled for amputation. Several years ago, an elderly man came to see me professionally. He had been a carpenter all his life and now 83 years old he was building homes through Habitat for Humanity. Specifically, he was working to rebuild homes destroyed by hurricane Katrina. He came to see me on the recommendation of another patient and because he was scheduled to have his right leg amputated. The amputation was deemed medically necessary because of damage to a major artery in his leg as the result of a previous vascular surgery. He and his doctors were concerned that he would not survive the surgery, but his main concern was that he would no longer be able to serve people through his Christian mission of rebuilding their damaged homes. His surgery was scheduled in six weeks (he was delaying it as long as possible) and his request of me was to save his leg. His leg was a mess. From just above the knee to his toes his leg was a tobacco brown color (he was a caucasian male). In addition to the extreme discoloration his skin was hardened like plastic. The tissue in the leg appeared to be dead, it had no softness to it. -
Roth 04 Pharmther Plant Derived Psychoactive Compounds.Pdf
Pharmacology & Therapeutics 102 (2004) 99–110 www.elsevier.com/locate/pharmthera Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery Bryan L. Rotha,b,c,d,*, Estela Lopezd, Scott Beischeld, Richard B. Westkaempere, Jon M. Evansd aDepartment of Biochemistry, Case Western Reserve University Medical School, Cleveland, OH, USA bDepartment of Neurosciences, Case Western Reserve University Medical School, Cleveland, OH, USA cDepartment of Psychiatry, Case Western Reserve University Medical School, Cleveland, OH, USA dNational Institute of Mental Health Psychoactive Drug Screening Program, Case Western Reserve University Medical School, Cleveland, OH, USA eDepartment of Medicinal Chemistry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, USA Abstract Because psychoactive plants exert profound effects on human perception, emotion, and cognition, discovering the molecular mechanisms responsible for psychoactive plant actions will likely yield insights into the molecular underpinnings of human consciousness. Additionally, it is likely that elucidation of the molecular targets responsible for psychoactive drug actions will yield validated targets for CNS drug discovery. This review article focuses on an unbiased, discovery-based approach aimed at uncovering the molecular targets responsible for psychoactive drug actions wherein the main active ingredients of psychoactive plants are screened at the ‘‘receptorome’’ (that portion of the proteome encoding receptors). An overview of the receptorome is given and various in silico, public-domain resources are described. Newly developed tools for the in silico mining of data derived from the National Institute of Mental Health Psychoactive Drug Screening Program’s (NIMH-PDSP) Ki Database (Ki DB) are described in detail. -
The Case of Artemisia Crithmifolia L. (Asteraceae, Anthemideae)
CARYOLOGIA Vol. 62, no. 2: 152-160, 2009 Changes in genome size in a fragmented distribution area: the case of Artemisia crithmifolia L. (Asteraceae, Anthemideae). Pellicer Jaume1, Sònia Garcia2, Teresa Garnatje2 and Joan Vallès1* 1 Laboratori de Botànica, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII, s.n., 08028 Barcelona, Catalonia, Spain. 2 Institut Botànic de Barcelona (CSIC-ICUB), Passeig del Migdia s.n., Parc de Montjuïc, 08038 Barcelona, Cata- lonia, Spain. Abstract — Artemisia crithmifolia is a hexaploid shrub which inhabits the coastal Atlantic sand dunes of Western Europe, from the Southern Iberian Peninsula to the Netherlands, reaching the British Isles. Genome size data of 45 populations of A. crithmifolia, covering its entire distribution area, were obtained using the flow cytometry method. The 2C nuclear DNA content in this species ranged from 14.27 to 15.72 pg, the mean value being 14.98 pg. A negative correlation between nuclear DNA amount and latitude has been found, and statistically significant differences between two groups resulting from the fragmentation of the distribution area were evidenced. Key words: 2C value, Compositae, dunes, flow cytometry, nuclear DNA amount. INTRODUCTION species occupies the maritime sands, principally at the back of the dunes in process of stabilization The genus Artemisia L. is one of the largest on the Northern Atlantic beaches, being part of of the Asteraceae, with more than 500 species two associations, Corynephoretum atlanticum and (OBERPRIELER et al. 2007). Different taxonomic Roseto-Ephedretum (KUHNZH O LTZ -LO RDAT 1927), rearrangements, based on morphological traits, which are closely related (VANDEN 1958). have been carried out, and five large subgenera Artemisia crithmifolia, a species from subgenus are considered at present (Absinthium DC., Ar- Dracunculus, presents capitula with glabrous re- temisia, Dracunculus Besser, Seriphidium Besser ceptacles, the outer florets female and the remain- and Tridentatae (Rydb.) McArthur). -
The Genus Artemisia: a 2012–2017 Literature Review on Chemical Composition, Antimicrobial, Insecticidal and Antioxidant Activities of Essential Oils
medicines Review The Genus Artemisia: A 2012–2017 Literature Review on Chemical Composition, Antimicrobial, Insecticidal and Antioxidant Activities of Essential Oils Abhay K. Pandey ID and Pooja Singh * Bacteriology & Natural Pesticide Laboratory, Department of Botany, DDU Gorakhpur University Gorakhpur, Uttar Pradesh 273009, India; [email protected] * Correspondence: [email protected]; Tel.: +91-941-508-3883 Academic Editors: Gerhard Litscher and Eleni Skaltsa Received: 8 August 2017; Accepted: 5 September 2017; Published: 12 September 2017 Abstract: Essential oils of aromatic and medicinal plants generally have a diverse range of activities because they possess several active constituents that work through several modes of action. The genus Artemisia includes the largest genus of family Asteraceae has several medicinal uses in human and plant diseases aliments. Extensive investigations on essential oil composition, antimicrobial, insecticidal and antioxidant studies have been conducted for various species of this genus. In this review, we have compiled data of recent literature (2012–2017) on essential oil composition, antimicrobial, insecticidal and antioxidant activities of different species of the genus Artemisia. Regarding the antimicrobial and insecticidal properties we have only described here efficacy of essential oils against plant pathogens and insect pests. The literature revealed that 1, 8-cineole, beta-pinene, thujone, artemisia ketone, camphor, caryophyllene, camphene and germacrene D are the major components in most of the essential oils of this plant species. Oils from different species of genus Artemisia exhibited strong antimicrobial activity against plant pathogens and insecticidal activity against insect pests. However, only few species have been explored for antioxidant activity. Keywords: Artemisia; essential oil; chemical composition; antimicrobial; insecticidal; antioxidant 1. -
Original Article in VITRO CYTOTOXIC PROPERTIES of SIX ARTEMISIA L
Turk J. Pharm. Sci. 8 (3), 247-252, 2011 Original article IN VITRO CYTOTOXIC PROPERTIES OF SIX ARTEMISIA L. SPECIES Şüra BAYKAN EREL1*, Serdar GÖKHAN ŞENOL2, Fadime AYDIN KÖSE3, Petek BALLAR 3 1Ege University, Faculty of Pharmacy, Department of Biochemistry, 35100 Bornova, İzmir, TURKEY 2Ege University, Faculty of Science, Department of Botany, 35100 Bornova, İzmir, TURKEY 3Ege University, Faculty of Pharmacy, Department of Pharmaceutical Botany, 35100 Bornova, İzmir, TURKEY Abstract Methanolic extracts of Artemisia L. taxons (Artemisia absinthium L., Artemisia arborescens L., Artemisia campestris L., Artemisia scoparia Waldst&Kit, Artemisia santonicum L., Artemisia vulgaris L. and Artemisia arborescens L.) were investigated for their cytotoxic activities against three human cancer cell lines, MCF7, A549, HeLa, and two human normal cell lines, A7R5 and 293T. The cytotoxic activities were analyzed by real-time cell analysis system measuring electrical impedance. Artemisia scoparia Waldst&Kit. showed significant effect on MCF7 (IC50: 34 jug/mL) and HeLa (LC50: 90 jug/mL). A. absinthium exhibited selective cytotoxic activity on MCF7 (IC50: 270 fig/mL). Key words: Artemisia, Cytotoxic, MCF7, A549, HeLa, A7R5, 293T. Altı Artemisia L. Türünün in vitro Sitotoksik Özellikleri Bu gahsmada Artemisia L. (Artemisia absinthium L., Artemisia arborescens L., Artemisia campestris L., Artemisia scoparia Waldst&Kit, Artemisia santonicum L., Artemisia vulgaris L. ve Artemisia arborescens L) Mrlerine ait metanollü ekstrelerin üg insan kanserli Mere hattında (MCF7, A549, HeLa) ve iki normal insan Mere hattında (A7R5 and 293T ) sitotoksik aktiviteleri araştinldı. Sitotoksik aktiviteler elektriksel empedans ölgen gergek zamanh Mere analiz sistemi He ölguldü. Sonugta Artemisia scoparia Waldst&Kit ekstresinin MCF7(LC50: 34 jug/mL) ve HeLa (LC50: 90 jug/mL) üzerinde oldukga yüksek aktivite gösterdiği saptandı.